Hyperbaric Oxygen Therapy: Evidence vs. Hype

How it works

What HBOT Actually Does

HBOT places a patient in a sealed chamber pressurized to typically 2.0–2.4 ATA while they breathe 100% oxygen. This dissolves dramatically more oxygen in plasma, drives oxygen into tissues with compromised blood supply, and triggers reduced inflammation, stem-cell mobilization, neovascularization, and altered immune signaling.

The mechanism is well-characterized. The clinical question is which conditions benefit at which protocol.

Approved indications

FDA-Approved and UHMS-Endorsed Indications

The Undersea and Hyperbaric Medical Society and FDA recognize a defined list:

• ·Decompression sickness, air or gas embolism, severe carbon monoxide poisoning.
• ·Necrotizing soft-tissue infections, gas gangrene, refractory osteomyelitis.
• ·Crush injury and acute traumatic ischemia, compromised skin grafts and flaps.
• ·Delayed radiation injury (osteoradionecrosis, soft-tissue radionecrosis, hemorrhagic cystitis).
• ·Non-healing diabetic foot ulcers (Wagner grade 3+).
• ·Severe anemia, intracranial abscess, idiopathic sudden sensorineural hearing loss, thermal burns.

Insurance covers HBOT for these. Evidence here is unambiguous.

Off-label & emerging

Off-Label, Emerging, and Wellness Use

• ·TBI and post-concussion syndrome — multiple RCTs with mixed results.
• ·Stroke recovery — small studies suggest benefit; large RCTs lacking.
• ·Long COVID — early studies suggest symptom improvement; not definitive.
• ·Cognitive aging and aging biomarkers — a 2020 Tel Aviv study (Hachmo et al.) showed telomere lengthening and reduced senescent cells in healthy older adults after 60 sessions; provocative, not yet replicated at scale.
• ·Athletic recovery, longevity, anti-aging — mostly mechanism and small studies.
• ·Autism, cerebral palsy, anti-inflammatory wellness — heavily marketed, weak evidence.

Chamber types

Hard-Shell Medical vs. Soft-Shell Wellness Chambers

This distinction matters and is often hidden by clinics:

• ·Hard-shell medical chambers operate at 2.0–2.4+ ATA with 100% oxygen. These deliver the protocols studied in medical literature.
• ·Soft-shell (mild) chambers operate at ~1.3 ATA, often with concentrated but not 100% oxygen. Total oxygen delivery is a small fraction of medical HBOT.

Using a soft chamber and citing hard-chamber research is a category error. Ask explicitly what pressure (ATA), oxygen percentage, and session length your protocol uses.

Cost

What HBOT Costs in 2026

• ·Insurance-covered medical HBOT: $0–$200 per session patient share.
• ·Cash-pay hard-chamber off-label: $200–$500 per session; longevity protocols of 40–60 sessions run $8,000–$30,000.
• ·Wellness clinic soft-chamber sessions: $75–$200 per session.
• ·Home soft-chamber rental or purchase: $5,000–$25,000 to own; $500–$1,500/month to rent.

Safety

Safety, Side Effects, and Contraindications

Good safety record when properly administered. Most side effects minor: middle-ear barotrauma (most common), temporary myopia with long courses, sinus barotrauma, rare oxygen toxicity seizures above 2.4 ATA, confined-space anxiety.

Contraindications: untreated pneumothorax, certain chemotherapy agents, severe COPD with CO2 retention, recent ear surgery.